Skip to main content
Top
Published in: Diabetologia 10/2006

01-10-2006 | Commentary

Diabetes and brain damage: more (or less) than meets the eye?

Author: Christopher M. Ryan

Published in: Diabetologia | Issue 10/2006

Login to get access

Excerpt

Brain damage is now a well-established complication of diabetes, but its pathophysiological basis remains controversial. Until very recently, most research on this topic was devoted to demonstrating that hypoglycaemic events are the primary cause of neurocognitive dysfunction. This was a plausible hypothesis because the central nervous system (CNS) has very limited stores of glucose and other substrates, but neurons have a very high rate of glucose utilisation; any reduction in glucose availability would probably induce neuroglycopenia, ultimately leading to significant neuronal damage. Support for this view came from research demonstrating that profound hypoglycaemia could produce neuronal necrosis [1] and induce distinctive patterns of neuropathological [2] and neurocognitive [3] impairment in humans who had experienced very low blood glucose levels over an extended period of time. Fortunately, most diabetic patients never experience profound hypoglycaemia. Although some writers have speculated that recurrent episodes of moderately severe hypoglycaemia could induce a less severe degree of neurocognitive dysfunction [4, 5], most recent studies of children [6] and adults [7, 8] have failed to find compelling evidence for that possibility. Taken together, these findings suggest that there is not a linear relationship between falling blood glucose levels and permanent brain dysfunction. Rather, necrotising neuronal damage occurs only after the threshold for cerebral energy failure is reached—most typically when blood glucose values fall below 1.5 mmol, and the electroencephalogram has reached an isoelectric (flat) state [9]. …
Literature
1.
go back to reference Auer RN, Wieloch T, Olsson Y, Siesjo BK (1984) The distribution of hypoglycemic brain damage. Acta Neuropathol [Berl] 64:177–191CrossRef Auer RN, Wieloch T, Olsson Y, Siesjo BK (1984) The distribution of hypoglycemic brain damage. Acta Neuropathol [Berl] 64:177–191CrossRef
2.
go back to reference Auer RN, Hugh J, Cosgrove E, Curry B (1989) Neuropathologic findings in three cases of profound hypoglycemia. Clin Neuropathol 8:63–68PubMed Auer RN, Hugh J, Cosgrove E, Curry B (1989) Neuropathologic findings in three cases of profound hypoglycemia. Clin Neuropathol 8:63–68PubMed
3.
go back to reference Chalmers J, Risk MTA, Kean DM, Grant R, Ashworth B, Campbell IW (1991) Severe amnesia after hypoglycemia. Diabetes Care 14:922–925PubMedCrossRef Chalmers J, Risk MTA, Kean DM, Grant R, Ashworth B, Campbell IW (1991) Severe amnesia after hypoglycemia. Diabetes Care 14:922–925PubMedCrossRef
4.
go back to reference Gold AE, Deary IJ, Frier BM (1993) Recurrent severe hypoglycaemia and cognitive function in type 1 diabetes. Diabet Med 10:503–508PubMedCrossRef Gold AE, Deary IJ, Frier BM (1993) Recurrent severe hypoglycaemia and cognitive function in type 1 diabetes. Diabet Med 10:503–508PubMedCrossRef
5.
go back to reference Perros P, Deary IJ, Sellar RJ, Best JJK, Frier BM (1997) Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 20:1013–1018PubMedCrossRef Perros P, Deary IJ, Sellar RJ, Best JJK, Frier BM (1997) Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 20:1013–1018PubMedCrossRef
6.
go back to reference Wysocki T, Harris MA, Mauras N et al (2003) Absence of adverse effects of severe hypoglycemia on cognitive function in school-aged children with diabetes over 18 months. Diabetes Care 26:1100–1105PubMedCrossRef Wysocki T, Harris MA, Mauras N et al (2003) Absence of adverse effects of severe hypoglycemia on cognitive function in school-aged children with diabetes over 18 months. Diabetes Care 26:1100–1105PubMedCrossRef
7.
go back to reference Brands AMA, Biessels G-J, De Haan EHF, Kappelle LJ, Kessels RPC (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28:726–735PubMedCrossRef Brands AMA, Biessels G-J, De Haan EHF, Kappelle LJ, Kessels RPC (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28:726–735PubMedCrossRef
8.
go back to reference Musen G, Lyoo IK, Sparks CR, Weinger K et al (2006) Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55:326–333PubMedCrossRef Musen G, Lyoo IK, Sparks CR, Weinger K et al (2006) Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55:326–333PubMedCrossRef
10.
go back to reference Ryan CM, Geckle MO, Orchard TJ (2003) Cognitive efficiency declines over time in adults with type 1 diabetes: effects of micro- and macrovascular complications. Diabetologia 46:940–948PubMedCrossRef Ryan CM, Geckle MO, Orchard TJ (2003) Cognitive efficiency declines over time in adults with type 1 diabetes: effects of micro- and macrovascular complications. Diabetologia 46:940–948PubMedCrossRef
11.
go back to reference Ferguson SC, Blane A, Perros P et al (2003) Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 52:149–156PubMedCrossRef Ferguson SC, Blane A, Perros P et al (2003) Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 52:149–156PubMedCrossRef
12.
go back to reference Wong TY, Klein R, Sharrett AR, et al (2002) Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke 33:1487–1492PubMedCrossRef Wong TY, Klein R, Sharrett AR, et al (2002) Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke 33:1487–1492PubMedCrossRef
13.
go back to reference Wong TY, Mosley TH, Klein R, et al, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators (2003) Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people. Neurology 61:806–811PubMed Wong TY, Mosley TH, Klein R, et al, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators (2003) Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people. Neurology 61:806–811PubMed
14.
go back to reference Cooper LS, Wong TY, Klein R et al (2003) Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke 37:82–86CrossRef Cooper LS, Wong TY, Klein R et al (2003) Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke 37:82–86CrossRef
15.
go back to reference Patton N, Aslam T, MacGillivray T, Pattie A, Deary IJ, Dhillon B (2005) Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat 206:319–348PubMedCrossRef Patton N, Aslam T, MacGillivray T, Pattie A, Deary IJ, Dhillon B (2005) Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat 206:319–348PubMedCrossRef
16.
go back to reference Wong TY, Klein R, Klein BEK, Tielsch JM, Hubbard L, Nieto FJ (2001) Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol 46:59–80PubMedCrossRef Wong TY, Klein R, Klein BEK, Tielsch JM, Hubbard L, Nieto FJ (2001) Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv Ophthalmol 46:59–80PubMedCrossRef
17.
go back to reference Ikram MK, De Jong FH, Van Dijk EJ et al (2006) Retinal vessel diameters and cerebral small vessel disease: The Rotterdam Scan Study. Brain 129:182–188PubMedCrossRef Ikram MK, De Jong FH, Van Dijk EJ et al (2006) Retinal vessel diameters and cerebral small vessel disease: The Rotterdam Scan Study. Brain 129:182–188PubMedCrossRef
18.
go back to reference Wessels AM, Simsek S, Remijnse PL et al (2006) Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia DOI 10.1007/s00125-006-0283-7 Wessels AM, Simsek S, Remijnse PL et al (2006) Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia DOI 10.​1007/​s00125-006-0283-7
19.
go back to reference Suter O-C, Sunthorn T, Kraftsik R et al (2002) Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 33:1986–1992PubMedCrossRef Suter O-C, Sunthorn T, Kraftsik R et al (2002) Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 33:1986–1992PubMedCrossRef
20.
go back to reference Wessels AM, Rombouts SARB, Simsek S et al (2006) Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study. Diabetes 55:334–340PubMedCrossRef Wessels AM, Rombouts SARB, Simsek S et al (2006) Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study. Diabetes 55:334–340PubMedCrossRef
21.
go back to reference Jennings JR, Muldoon MF, Ryan C et al (2005) Reduced cerebral blood flow response and compensation among patients with untreated hypertension. Neurology 64:1358–1365PubMed Jennings JR, Muldoon MF, Ryan C et al (2005) Reduced cerebral blood flow response and compensation among patients with untreated hypertension. Neurology 64:1358–1365PubMed
22.
go back to reference Schmidt R, Launer LJ, Nilsson L-G et al (2004) Magnetic resonance imaging of the brain in diabetes: The Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 53:687–692PubMedCrossRef Schmidt R, Launer LJ, Nilsson L-G et al (2004) Magnetic resonance imaging of the brain in diabetes: The Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 53:687–692PubMedCrossRef
23.
go back to reference Hassing LB, Hofer SM, Nilsson SE et al (2004) Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 33:355–361PubMedCrossRef Hassing LB, Hofer SM, Nilsson SE et al (2004) Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 33:355–361PubMedCrossRef
24.
go back to reference Elias PK, Elias MF, D’Agostino RB, Cupples LA et al (1997) NIDDM and blood pressure as risk factors for poor cognitive performance. Diabetes Care 20:1388–1395 Elias PK, Elias MF, D’Agostino RB, Cupples LA et al (1997) NIDDM and blood pressure as risk factors for poor cognitive performance. Diabetes Care 20:1388–1395
25.
go back to reference Quirce R, Carril JM, Jiménez-Bonilla JF et al (1997) Semi-quantitative assessment of cerebral blood flow with 99mTc-HMPAO SPET in type 1 diabetic patients with no clinical history of cerebrovascular disease. Eur J Nucl Med 24:1507–1513PubMedCrossRef Quirce R, Carril JM, Jiménez-Bonilla JF et al (1997) Semi-quantitative assessment of cerebral blood flow with 99mTc-HMPAO SPET in type 1 diabetic patients with no clinical history of cerebrovascular disease. Eur J Nucl Med 24:1507–1513PubMedCrossRef
26.
go back to reference Salem MAK, Matta LF, Tantawy AAG, Hussein M, Gad GI (2002) Single photon emission tomography (SPECT) study of regional cerebral blood flow in normoalbuminuric children and adolescents with type1diabetes. Pediatr Diabetes 3:155–162PubMedCrossRef Salem MAK, Matta LF, Tantawy AAG, Hussein M, Gad GI (2002) Single photon emission tomography (SPECT) study of regional cerebral blood flow in normoalbuminuric children and adolescents with type1diabetes. Pediatr Diabetes 3:155–162PubMedCrossRef
27.
go back to reference Fülesdi B, Limburg M, Bereczki D et al (1997) Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes 46:1840–1845PubMedCrossRef Fülesdi B, Limburg M, Bereczki D et al (1997) Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes 46:1840–1845PubMedCrossRef
28.
go back to reference Kario K, Ishikawa J, Hoshide S et al (2005) Diabetic brain damage in hypertension: role of renin–angiotensin system. Hypertension 45:887–893PubMedCrossRef Kario K, Ishikawa J, Hoshide S et al (2005) Diabetic brain damage in hypertension: role of renin–angiotensin system. Hypertension 45:887–893PubMedCrossRef
29.
go back to reference Mäkimattila S, Malmberg-Cèder K, Häkkinen A-M et al (2004) Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury. J Cereb Blood Flow Metab 24:1393–1399PubMedCrossRef Mäkimattila S, Malmberg-Cèder K, Häkkinen A-M et al (2004) Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury. J Cereb Blood Flow Metab 24:1393–1399PubMedCrossRef
30.
go back to reference Ruitenberg A, Den Heijer T, Bakker SLM et al (2005) Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam Study. Ann Neurol 57:789–794PubMedCrossRef Ruitenberg A, Den Heijer T, Bakker SLM et al (2005) Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam Study. Ann Neurol 57:789–794PubMedCrossRef
31.
go back to reference De La Torre JC (2004) Alzheimer’s disease is a vasocognopathy: a new term to describe its nature. Neurol Res 26:517–524PubMedCrossRef De La Torre JC (2004) Alzheimer’s disease is a vasocognopathy: a new term to describe its nature. Neurol Res 26:517–524PubMedCrossRef
32.
go back to reference De La Torre JC (2004) Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 3:184–190PubMedCrossRef De La Torre JC (2004) Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 3:184–190PubMedCrossRef
33.
go back to reference Cukierman T, Gerstein HC, Williamson JD (2005) Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies. Diabetologia 48:2460–2469PubMedCrossRef Cukierman T, Gerstein HC, Williamson JD (2005) Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies. Diabetologia 48:2460–2469PubMedCrossRef
34.
go back to reference Biessels G-J, Staekenborg S, Brunner E, Scheltens P (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5:64–74PubMedCrossRef Biessels G-J, Staekenborg S, Brunner E, Scheltens P (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5:64–74PubMedCrossRef
35.
go back to reference Reske-Nielsen E, Lundbaek K, Rafaelsen OJ (1965) Pathological changes in the central and peripheral nervous system of young long-term diabetics. Diabetologia 1:232–241 Reske-Nielsen E, Lundbaek K, Rafaelsen OJ (1965) Pathological changes in the central and peripheral nervous system of young long-term diabetics. Diabetologia 1:232–241
36.
go back to reference Meyer JS, Rauch G, Rauch RA, Haque A (2000) Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Neurobiol Aging 21:161–169PubMedCrossRef Meyer JS, Rauch G, Rauch RA, Haque A (2000) Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Neurobiol Aging 21:161–169PubMedCrossRef
37.
go back to reference Qiu C, Winblad B, Fratiglioni L (2005) The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4:487–499PubMedCrossRef Qiu C, Winblad B, Fratiglioni L (2005) The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4:487–499PubMedCrossRef
38.
go back to reference Brands AMA, Kessels RPC, Biessels GJ et al (2006) Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes 55:1800–1806PubMedCrossRef Brands AMA, Kessels RPC, Biessels GJ et al (2006) Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes 55:1800–1806PubMedCrossRef
39.
go back to reference van den Berg E, De Craen AJM, Biessels GJ, Gusselkloo J, Westendorp RGJ (2006) The impact of diabetes mellitus on cognitive decline in the oldest of the old: a prospective population-based study. Diabetologia 49:2015–2023PubMedCrossRef van den Berg E, De Craen AJM, Biessels GJ, Gusselkloo J, Westendorp RGJ (2006) The impact of diabetes mellitus on cognitive decline in the oldest of the old: a prospective population-based study. Diabetologia 49:2015–2023PubMedCrossRef
40.
go back to reference Peterson RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303–308CrossRef Peterson RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303–308CrossRef
41.
go back to reference Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61:661–666PubMedCrossRef Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61:661–666PubMedCrossRef
Metadata
Title
Diabetes and brain damage: more (or less) than meets the eye?
Author
Christopher M. Ryan
Publication date
01-10-2006
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2006
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0392-3

Other articles of this Issue 10/2006

Diabetologia 10/2006 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.